Cancers of the Urinary Bladder, Ureters and Urethra

  • L. Denis
  • R. Hall
  • G. Jakse

Abstract

Transitional cell epithelium (urothelium) lines the urinary tract from the calyces of the kidney to the urethra, including the ducts of the prostate. Transitional cell cancer (TCC) accounts for 95% of all urothelial tumours. Almost all TCC originates in the bladder as ureteral and urethral cancers are relatively rare. Bladder cancer of this type will be the subject of this chapter.

Keywords

Fatigue Radium Oncol Doxorubicin Methotrexate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beahrs OH, Myers MH (1983) Manual for staging of cancer. American Joint Committee on Cancer. Lippincott, PhiladelphiaGoogle Scholar
  2. Blandy JP, England HR, Evans SJW, Hope-Stone HF, Mair GMM, Mantell BS, Oliver RTD, Paris AMI, Risdon RA (1980) T3 bladder cancer - the case for salvage cystectomy. Br J Urol 52: 506–510PubMedCrossRefGoogle Scholar
  3. Bloom HGH, Hendry WF, Wallace DM, Skeet RG (1982) Treatment of T3 bladder cancer: controlled trial of preoperative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 54: 136–151PubMedCrossRefGoogle Scholar
  4. Bouffieux C, Denis L, Kurth KH, de Paine M, Sylvester R et le groupe genitourinaire de l’EORTC (1988) Quel chimiothera-pie intravesicale pour quelle tumeur de vessie. J Urol (Paris) (in print)Google Scholar
  5. Carney M, le Due A (1979) L’enterocystoplastie apres cystecto-mie totale pour cancer de la vessie. Ann Urol (Paris) 2: 642–658Google Scholar
  6. Corder MP, McFadden DB, Stump DC (1984) Chemotherapy of advanced transitional cell carcinoma of the bladder. In: Smith PH, Prout GR Jr (eds) Bladder cancer - urology I. Butterworths International Medical Reviews, London, pp 240–276Google Scholar
  7. Crawford ED, Das S, Smith JA (1987) Preoperative radiation therapy in the treatment of bladder cancer. Urol Clin North Am 14: 781–787PubMedGoogle Scholar
  8. Cutler SJ, Heney NM, Friedell GH (1982) Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In: Bonney WW (ed) AUA monographs, vol 1: Bladder cancer. Williams and Wilkins, Baltimore, pp 35–46Google Scholar
  9. Dalesio O, Schulman CC, Sylvester R, de Pauw M, Robinson M, Denis L, Smith P, Viggiano G, members of the EORTC Genito-Urinary Tract Cooperative Group (1983) Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer Genito-Urinary Tract Cooperative Group. J Urol 129: 730–733PubMedGoogle Scholar
  10. Denis L (1987) Deeply invasive transitional cell carcinoma. In: Resnick MI, Kursh E (eds) Current therapy in genito-uri-nary surgery. Decker, Toronto, pp 63–69Google Scholar
  11. Denis L, Smith P, Pavone-Macaluso M (1982) Clinical bladder cancer. Plenum, New YorkCrossRefGoogle Scholar
  12. Denis L, Braeckman J, Keuppens F (1984 a) Ultrasonography and computed tomography in the staging of bladder and prostate cancer. In: Kurth K, Debruyne F, Schroder F, Splinter T, Wagener T (eds) Progress and controversies in oncological urology. Liss, New York, pp 3–21Google Scholar
  13. Denis L, Hendrickx G, Braeckman J, Debruyne R (1984 b) Interest of preoperative chemotherapy in the treatment of infiltrative bladder cancer. Acta Urol Belg 52: 579–582PubMedGoogle Scholar
  14. Denis L, Murphy G, Prout G, Schroder F (1984 c) Controlled clinical trials in urologic oncology. Raven, New YorkGoogle Scholar
  15. Denis L, Dalesio O, van Oosterom AT (1986 b) Bladder cancer. In: Slevin ML, Staquet MJ (eds) Randomized trials in cancer: a critical review by sites. Raven, New York, pp 645–660Google Scholar
  16. Denis L, Niijima T, Prout GR, Schroder F. (eds) (1986 b) Developments in bladder cancer. Liss, New YorkGoogle Scholar
  17. Denis L, Calais de Silva F, Hendrickx G (1988) Preoperative chemotherapy in T3 T4 NX M0 bladder cancer with cispla-tin and methotrexate. In: Smith PH, Pavone-Macaluso M (eds) Management of advanced cancer of the prostate and bladder. Liss, New York, pp 571–577Google Scholar
  18. Fagg SL, Dawson-Edwards P, Hughes MA, Latief TN, Rolfe EB, Fielding JWL (1984) Cisplatinum (DDP) as initial treatment of invasive bladder cancer. Br J Urol 56: 296PubMedCrossRefGoogle Scholar
  19. Friedell GH (1976) Carcinoma, carcinoma in situ and “early lesions” of the uterine and the urinary bladder: introduction and definitions. Cancer Res 36: 2482–2484PubMedGoogle Scholar
  20. Hall RR, Heath AB (1981) Radiotherapy and cystectomy for T3 bladder cancer. Br J Urol 53: 598–601PubMedCrossRefGoogle Scholar
  21. Hall RR, Newling DWW, Ramsden PD, Richards B, Robinson MRG, Smith PH (1984) Treatment of invasive bladder cancer by local resection and high dose methotrexate. Br J Urol 56: 668–672PubMedCrossRefGoogle Scholar
  22. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Haferman MD, Hawkings IR (1983) Superficial bladder cancer: progression and recurrence. J Urol 130:1083–1086PubMedGoogle Scholar
  23. Hermanek P, Sobin LH (1987) TNM classification of malignant tumours. Springer, Berlin Heidelberg New YorkGoogle Scholar
  24. Herr H, Landone VP, Whitmore FW Jr (1987) An overview of intravesical chemotherapy for superficial bladder tumours. J Urol 138: 1363–1368PubMedGoogle Scholar
  25. Hohenfellner RH, Jacobi GH (1984) Radical cystectomy without preoperative radiotherapy for invasive bladder carcinoma: a justified approach? In: Kurth KH, Debruyne FMJ, Schroder FH, Splinter TAW, Wagener TDJ (eds) Progress and controversies in oncological urology. Liss, New York, pp 313–342Google Scholar
  26. Jakse G, Frommhold H (1984) Combined radiation and chemotherapy for locally advanced bladder cancer. In: Kurth KH, Debruyne F, Schroder F, Splinter T, Wagener T (eds) Progress and controversies in oncological urology. Liss, New York, pp 365–372Google Scholar
  27. Jakse G, Marberger H (1985) Culp D, Loening S. (eds) Tumours of the ureter in genito-urinary oncology. Lea and Fehger, Philadelphia, p 277Google Scholar
  28. Jakse G, Hofstadter F, Leitner G (1980) Carcinoma in situ der Harnblase. Urologe [A] 19: 93–99Google Scholar
  29. Kock NG (1971) Ileostomy without external appliances. Ann Surg 173: 545–566PubMedCrossRefGoogle Scholar
  30. Koss LG, Deitch D, Ramanathan R, Sherman A (1985) Diagnostic value of cytology of voided urine. Acta Cytol (Baltimore) 29: 810–816Google Scholar
  31. Kurth KH (1984) Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival. In: Küss R, Khoury S, Denis L, Murphy GP, Karr JP (eds) Bladder cancer. A. Pathology, diagnosis and surgery. Liss, New York, pp 307–318Google Scholar
  32. Medical Research Council Working Party on Urological Cancer (1985) The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer: an MRC study. Br J Urol 57: 680–685Google Scholar
  33. Miyakawa M, Raghavan D, Riedl H, Robinson MRG, Worden JN (1986) Quality of life assessment in bladder cancer clinical trials: conceptual, methodological and practical issues. In: Denis L, Niijima T, Prout GR, Schroder F (eds) Consensus in bladder cancer. Liss, New York, pp 149–170Google Scholar
  34. Morales A (1984) Long term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer. J Urol 132: 452–457Google Scholar
  35. Neal DE (1985) Complications of ileal conduit diversion in adults with cancer followed up for at least five years. Br Med J [Clin Res] 290: 1695–1697CrossRefGoogle Scholar
  36. Niijima T, Nakamura S (1982) Transurethral ultrasonography: bladder cancer staging and other clinical application. In: Denis L, Smith PH, Pavone-Macaluso M (eds) Clinical bladder cancer. Plenum, New York, pp 47–54CrossRefGoogle Scholar
  37. Powell PH, Manohar V, Ramsden PD, Hall RR (1984) A flexible cystoscope. Br J Urol 56: 622–624PubMedCrossRefGoogle Scholar
  38. Prout GR Jr, Kopp J (1984) Evaluation and management of patients with primary bladder carcinoma protocols of the NBCP Collaborative Group A. In: Denis L, Murphy G, Prout G, Schroder F (eds) Controlled clinical trials. Raven, New York, pp 221–240Google Scholar
  39. Prout GR Jr, Griffin PP, Shipley WU (1979) Bladder carcinoma as a systemic disease. Cancer 43: 2532–2539PubMedCrossRefGoogle Scholar
  40. Prout GR Jr, Koontz WW Jr, Coombs LJ, Hawkings IR, Friedell GH for the National Bladder Collaborative Group A (1983) Long term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not receive thiotepa. J Urol 130: 677–680PubMedGoogle Scholar
  41. Raghavan D, Pearson B, Duval P, Rogers J, Meagher M, Wines R, Mameghan H, Boulas J, Green D (1985) Initial intravenous cisplatinum therapy: improved management for invasive high risk bladder cancer? J Urol 133: 399–402PubMedGoogle Scholar
  42. Richards B, Schroder F (1983) Superficial bladder tumours. Liss, New YorkGoogle Scholar
  43. Richards B, Bastable JR, Freedman L, Glashan RW, Harris G, Newling W, Robinson MR, Smith PH (1983) Adjuvant chemotherapy with doxorubicin (adriamycin) and 5-fluoro-uracil in T3 NX M0 bladder cancer treated with ratiother-apy. Br J Urol 55: 386–391PubMedCrossRefGoogle Scholar
  44. Richards B, Aso Y, Bollack C, Fossa S, Koontz W, Matsuda M, Matsumoto K, Prout G, van der Werf-Messing B, Wolf H (1986) Prognostic factors in infiltrating bladder cancer. In: Denis L, Niijima T, Prout GR, Schroder F (eds) Developments in bladder cancer. Liss, New York, pp 271–286Google Scholar
  45. Shipley WV, Rose MA (1984) Bladder cancer. The selection of patients for full-dose irradiation. Cancer 55: 2278–2284CrossRefGoogle Scholar
  46. Shipley WV, Prout GR Jr, Einstein AB (1987) Treatment of invasive bladder cancer by cisplatin and irradiation in patients unsuited for surgery. JAMA 258: 931–937PubMedCrossRefGoogle Scholar
  47. Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128: 34–36PubMedGoogle Scholar
  48. Skinner D, Lieskorsky G, Boyd SD (1987) Continuing experience with the continent ileal reservoir (Kock pouch) as an alternative to cutaneous urinary diversion: an update after 250 cases. J Urol 137: 1140–1145PubMedGoogle Scholar
  49. Slack NH, Prout GR (1980) The heterogeneity of invasive bladder carcinoma and different responses to treatment. J Urol 123: 644–652PubMedGoogle Scholar
  50. Slack NH, Bross IDJ, Prout GR Jr (1977) Five year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J Surg Oncol 9: 393–405PubMedCrossRefGoogle Scholar
  51. Socquet Y (1981) Combined surgery and adjuvant chemotherapy with high dose methotrexate and folinic acid rescue (HDMTX-CF) for infiltrating tumours of the bladder. Br J Urol 53: 439–443PubMedCrossRefGoogle Scholar
  52. Soloway M, Kurth KH, Herr H, Huland H, Denis L, Suzuki K, Blandy J, Hisazumi H, Koontz W, Tsugawa R (1986) Surgical techniques in the management of patients with superficial bladder cancer. In: Denis L, Niijima T, Prout GR, Schroder F. (eds) Developments in bladder cancer. Liss, New York, pp 123–132Google Scholar
  53. Sonoda T, Debruyne FMJ, Prout GR Jr, Matsuda M, Blandy JP, Hohenfellner R, Keuppens F, Matsumoto K, Ogata J, Whitmore WF Jr (1986) Surgical techniques in invasive bladder cancer. In: Denis L, Niijima T, Prout GR, Schroder F (eds) Developments in bladder cancer. Liss, New York, pp 138–148Google Scholar
  54. Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Sogoni PC, Morse MJ, Fair WR, Whitmore WF, Vaughan ED, Bander N, Weiselberg LR, Geller N, Hollander PS (1988) M-VAC for advanced transitional cell carcinoma of urothe-lium. J Urol 139: 461–469PubMedGoogle Scholar
  55. Stoter G (1985) Chemotherapy for metastatic bladder carcinoma. World J Urol 3: 110–114CrossRefGoogle Scholar
  56. Stoter G, Child JA, Fossa SD, Boven E, Denis L, Splinter WG, van Oosterom AT, de Pauw M, Sylvester R for the EORTC Genito-Urinary Group (1987) Combination chemotherapy with cisplatin (CDDP) and methotrexate (MIX) in advanced transitional cell cancer of the bladder. J Urol 137: 663–667PubMedGoogle Scholar
  57. Sylvester R (1985) The analysis of results in prophylactic superficial bladder cancer. In: Schroder FH, Richards B (eds) Superficial bladder tumours. Liss, New York, pp 3–11Google Scholar
  58. Sylvester TAW, ten Kate FJW, Schroder FH, Denis L, Newling D, Jones WG, Jacquimin D, Becker-Kruger CGG, Sloter G, de Voegt HJ, de Paine M (1988) Neo-adjuvant chemotherapy in T3–4 NO-X MO transitional cell carcinoma of the bladder. In: Khoury S, Murphy G, Chatelain C, Dews L (eds) Therapeutic progress in urological cancers. Liss, New York (in print)Google Scholar
  59. van der Werf-Messing B (1983) Radiation therapy of carcinoma of the urinary bladder in clinical bladder cancer. In: Denis L, Murphy G, Prout G, Schroder F (eds) Controlled clinical trials in urologic oncology. Raven, New York, pp 83–89Google Scholar
  60. Van der Werf-Messing B, Menon RS, Hopp WC (1984) Interstitial radiotherapy of carcinoma of the bladder at the Rotterdam Radiotherapy Institute (RRTI). In: Küss R, Khoury S, Denis L, Murphy G, Karr JP (eds) Bladder cancer. Liss, New York, pp 71–85Google Scholar
  61. Whitmore WF, Batata MA, Ghoneim MA, Grabstald H, Unal A (1977) Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol 118: 184–187PubMedGoogle Scholar
  62. Wolf H, Olsen PR, Hojgaard K (1985) Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences in patients treated with full course radiotherapy. Lancet I: 1005CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • L. Denis
  • R. Hall
  • G. Jakse

There are no affiliations available

Personalised recommendations